Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Nephrogenic systemic fibrosis is associated with transforming growth factor beta and Smad without evidence of renin-angiotensin system involvement.

Kelly B, Petitt M, Sanchez R.

J Am Acad Dermatol. 2008 Jun;58(6):1025-30. doi: 10.1016/j.jaad.2008.02.038.

PMID:
18485985
2.

Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.

Schieren G, Gambichler T, Skrygan M, Burkert B, Altmeyer P, Rump LC, Kreuter A.

Am J Kidney Dis. 2010 Jun;55(6):1040-9. doi: 10.1053/j.ajkd.2010.01.021. Epub 2010 Apr 28. Erratum in: Am J Kidney Dis. 2010 Jul;56(1):187.

PMID:
20430497
3.
4.

[Renal gene expression of renin and transforming growth factor Beta 1 in children with glomerulonephritis].

Ciechanowicz A, Brodkiewicz A, Adler G, Kurzawska O, Juszkiewicz P, Krygier-Stojałowska A, Fydryk J.

Pol Merkur Lekarski. 2001 Apr;10(58):250-5. Polish.

PMID:
11434169
5.

Novel aspects of the renin-angiotensin-aldosterone-system.

Wolf G.

Front Biosci. 2008 May 1;13:4993-5005. Review.

PMID:
18508564
6.

Transforming growth factor-beta and angiotensin in fibrosis and burn injuries.

Gabriel VA.

J Burn Care Res. 2009 May-Jun;30(3):471-81. doi: 10.1097/BCR.0b013e3181a28ddb. Review.

PMID:
19349880
7.

NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets Smad.

Rocic P, Lucchesi PA.

Circ Res. 2005 Oct 28;97(9):850-2. No abstract available.

8.
9.

Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.

Geirsson A, Singh M, Ali R, Abbas H, Li W, Sanchez JA, Hashim S, Tellides G.

Circulation. 2012 Sep 11;126(11 Suppl 1):S189-97.

10.

Early activation of fibrogenesis in transplanted kidneys: a study on serial renal biopsies.

Del Prete D, Ceol M, Anglani F, Vianello D, Tiralongo E, Valente M, Graziotto R, Bonfante L, Scaparrotta G, Furian L, Rigotti P, Gambaro G, D'Angelo A.

Exp Mol Pathol. 2009 Oct;87(2):141-5. doi: 10.1016/j.yexmp.2009.07.004. Epub 2009 Jul 16.

PMID:
19616542
11.

Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells.

Zheng R, Xiong Q, Zuo B, Jiang S, Li F, Lei M, Deng C, Xiong Y.

Cell Biochem Funct. 2008 Sep-Oct;26(5):548-56. doi: 10.1002/cbf.1464.

PMID:
18506886
13.

Smad3 mediates angiotensin II- and TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot.

Sorescu D.

Circ Res. 2006 Apr 28;98(8):988-9. No abstract available.

14.

TGF-beta, Smad3 and the process of progressive fibrosis.

Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M.

Biochem Soc Trans. 2007 Aug;35(Pt 4):661-4. Review.

PMID:
17635115
15.

Pathophysiology of acute kidney injury: a new perspective.

Wen X, Murugan R, Peng Z, Kellum JA.

Contrib Nephrol. 2010;165:39-45. doi: 10.1159/000313743. Epub 2010 Apr 20.

PMID:
20427954
16.
17.
18.

Intramuscular renin-angiotensin system is activated in human muscular dystrophy.

Sun G, Haginoya K, Dai H, Chiba Y, Uematsu M, Hino-Fukuyo N, Onuma A, Iinuma K, Tsuchiya S.

J Neurol Sci. 2009 May 15;280(1-2):40-8. doi: 10.1016/j.jns.2009.01.020. Epub 2009 Feb 20.

PMID:
19232644
19.

Decorin is significantly overexpressed in nephrogenic systemic fibrosis.

Gambichler T, Kreuter A, Skrygan M, Burkert B, Altmeyer P, Schieren G.

Am J Clin Pathol. 2009 Jul;132(1):139-43. doi: 10.1309/AJCPGB55YDURJXZC.

20.
Items per page

Supplemental Content

Write to the Help Desk